Assessment of differences in nutrients consumption in women diagnosed with osteoporosis as compared to a healthy control group

• Published in: Roczniki Państwowego Zakładu Higieny Vol. 68; no. 2; pp. 143 - 149
• Main Authors: Wawrzyniak, Agata, Klimczyk, Patrycja, Woźniak, Agnieszka, Anyżewska, Anna, Leonkiewicz, Magdalena
• Format: Journal Article
• Language: English
• Published: Poland 2017
• Subjects: Aged; Diet; Diet Surveys; Female; Humans; Micronutrients; Middle Aged; Nutritive Value; Osteoporosis - physiopathology; Poland
• ISSN: 0035-7715

Osteoporosis is a condition that has been much more frequent for women, which is related to menopause and to their lower bone mineral density (BMD). Inappropriate diet is among the development factors of the disease. To assess differences in consumption of particular nutrients among women with and without osteoporosis diagnosed. The study was conducted in 2013 in a group of 100 women aged 51-70, using a questionnaire, including a 24-hour recall related to a participant’s nutrients consumptions. Women suffering from osteoporosis were found to consume significantly lower amounts of fat (by 16%) and energy (by 13%), as well as vitamins: A (by 16%), E (by 20%), B6 (by 20%), niacin (by 16%) and C (by 19%). Differences in the consumption of minerals have been observed in the cases of calcium, phosphorus, sodium and potassium. The women with osteoporosis were fund to consume lower amounts of those elements, by 14%, 13%, 21% and 19% respectively. On the average, participants of the study in both groups consumed amounts of calcium at a half of the recommended level, and substantially exceeded the recommended values of phosphorus, as well as displaying an inappropriate calcium to phosphorus ratio (0.5:1). As little as 8% of the participants with osteoporosis declared a considerable change in their diet, with increased consumption of dairy products. The observed nutrition deficiencies in osteoporosis patients may be conducive to a worsened condition, and may lead to an onset of the disease in participants from the control group.